Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#161 / 200 Total
BVS - Bioventus Inc - Stock Price Chart
TickerBVS [NASD]
CompanyBioventus Inc
CountryUSA
IndustryMedical Devices
Market Cap348.51MEPS (ttm)-0.34
P/E-EPS this Y1281.66%
Forward P/E12.22EPS next Y61.73%
PEG-EPS past 5Y-51.10%
P/S0.67EPS next 5Y-
P/B2.03EPS Q/Q96.78%
Dividend-Sales Q/Q8.73%
Insider Own43.27%Inst Own32.18%
Insider Trans-0.07%Inst Trans2.03%
Short Float2.17%EarningsMay 07/b
Analyst Recom2.33Target Price8.50
Avg Volume201.83K52W Range0.95 - 6.08
Bioventus, Inc. is a medical technology company, which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. It operates through the following business segments: Active Healing Therapies-U.S, Active Healing Therapies-International, Surgical and BMP. The Active Healing Therapies-U.S and International offers two types of non-surgical products which are non-invasive exogen system for long bone stimulation for fracture healing and hyaluronic acid, or HA, viscosupplementation therapies for osteoarthritis pain relief. The Surgical segment offers a portfolio of advanced bone graft substitutes. The BMP segment comprises proprietary next-generation bone morphogenetic protein, or BMP. The company was founded on November 23, 2011 and is headquartered in Durham, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Singleton Mark LeonardSVP & CFOApr 11 '24Sale4.754,00019,00034,665Apr 15 06:03 PM
D'Adamio AnthonySVP & General CounselApr 11 '24Sale4.753,05414,50658,242Apr 15 06:00 PM
CHURCH KATRINA JSVP & Chief Compliance OfficerApr 11 '24Sale4.751,3256,29417,042Apr 15 05:58 PM
Singleton Mark LeonardSVP & CFOMar 22 '24Sale5.395,54129,85325,665Mar 25 05:36 PM
D'Adamio AnthonySVP & General CounselMar 15 '24Sale5.463,12517,06251,371Mar 20 06:41 PM
PLG - Platinum Group Metals Ltd. - Stock Price Chart
TickerPLG [AMEX]
CompanyPlatinum Group Metals Ltd.
CountryCanada
IndustryOther Precious Metals & Mining
Market Cap147.57MEPS (ttm)-0.05
P/E-EPS this Y16.67%
Forward P/E-EPS next Y40.00%
PEG-EPS past 5Y51.11%
P/S-EPS next 5Y-
P/B5.79EPS Q/Q34.17%
Dividend-Sales Q/Q-
Insider Own26.61%Inst Own19.55%
Insider Trans0.00%Inst Trans29.62%
Short Float1.29%EarningsApr 16/a
Analyst Recom2.50Target Price1.19
Avg Volume292.37K52W Range0.94 - 1.73
Platinum Group Metals Ltd. engages in the acquisition, exploration, and development of platinum and palladium properties. It operates through Canada and South Africa geographical segment. The company was founded by R. Michael Jones on January 10, 2000 and is headquartered in Vancouver, Canada.
NUZE - Nuzee Inc - Stock Price Chart
TickerNUZE [NASD]
CompanyNuzee Inc
CountryUSA
IndustryPackaged Foods
Market Cap3.08MEPS (ttm)-10.59
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-3.14%
P/S0.86EPS next 5Y-
P/B3.09EPS Q/Q43.02%
Dividend-Sales Q/Q19.15%
Insider Own17.76%Inst Own11.70%
Insider Trans0.00%Inst Trans-
Short Float0.52%EarningsJan 17/b
Analyst Recom1.00Target Price8.00
Avg Volume532.52K52W Range1.13 - 13.00
NuZee, Inc. is a coffee and technologies company, which engages in the manufacture, market, distribution, commercialization, and development of functional beverages products. Its products include single serve pour over, Dripkit pour over, coffee brew bag, private label, and licensing under the Stone Brewing Coffee and Dripkit brands. It operates through the North America and South Korea geographical segments. The company was founded on November 9, 2011 and is headquartered in Richardson, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HIGASHIDA MASATERUSee RemarksOct 13 '23Sale5.165002,580133,059Oct 16 04:48 PM
HIGASHIDA MASATERUSee RemarksSep 14 '23Sale7.378005,896133,558Sep 15 08:20 PM
HIGASHIDA MASATERUSee RemarksSep 13 '23Sale7.331,2008,796134,358Sep 15 08:20 PM
SCWO - 374Water Inc - Stock Price Chart
TickerSCWO [NASD, RUT]
Company374Water Inc
CountryUSA
IndustryPollution & Treatment Controls
Market Cap192.37MEPS (ttm)-0.05
P/E-EPS this Y-16.67%
Forward P/E-EPS next Y14.29%
PEG-EPS past 5Y-23.79%
P/S116.59EPS next 5Y-
P/B11.01EPS Q/Q-81.94%
Dividend-Sales Q/Q-98.67%
Insider Own52.74%Inst Own10.98%
Insider Trans0.00%Inst Trans38.85%
Short Float6.20%EarningsMar 31/a
Analyst Recom1.00Target Price2.50
Avg Volume106.24K52W Range0.97 - 3.46
374Water, Inc. is a clean technology company. It offers supercritical water oxidation (SWCO) waste processors. It caters to municipal and industrial wastewater treatment plants, food waste, chemical plants, and army camps and emergency situations. The company was founded by Yaacov Nagar and Marc Deshusses on September 8, 2005 and is headquartered in Durham, NC.
CLGN - CollPlant Biotechnologies Ltd - Stock Price Chart
TickerCLGN [NASD]
CompanyCollPlant Biotechnologies Ltd
CountryIsrael
IndustryBiotechnology
Market Cap77.29MEPS (ttm)-0.63
P/E-EPS this Y-90.32%
Forward P/E-EPS next Y55.93%
PEG-EPS past 5Y-84.92%
P/S7.05EPS next 5Y-
P/B2.73EPS Q/Q-4.07%
Dividend-Sales Q/Q415.52%
Insider Own31.25%Inst Own17.65%
Insider Trans0.00%Inst Trans-7.02%
Short Float0.11%EarningsApr 04/b
Analyst Recom1.00Target Price16.88
Avg Volume6.56K52W Range4.22 - 8.90
CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. Its products include VergenixSTR, VergenixFG, and Collink.3D. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.
MNOV - Medicinova Inc - Stock Price Chart
TickerMNOV [NASD]
CompanyMedicinova Inc
CountryUSA
IndustryBiotechnology
Market Cap71.61MEPS (ttm)-0.17
P/E-EPS this Y-35.29%
Forward P/E-EPS next Y-4.35%
PEG-EPS past 5Y13.30%
P/S71.61EPS next 5Y20.00%
P/B1.15EPS Q/Q31.37%
Dividend-Sales Q/Q-
Insider Own5.24%Inst Own18.78%
Insider Trans0.00%Inst Trans-0.93%
Short Float0.53%EarningsFeb 16/b
Analyst Recom1.00Target Price16.50
Avg Volume49.29K52W Range1.26 - 2.66
Today 07:45PM MediciNova: Q1 Earnings Snapshot (Associated Press Finance) +8.15%
May-07-24 06:00AM MediciNova Receives Issue Notification for New Patent Covering Extended-Release Formulations of MN-166 (ibudilast) (GlobeNewswire)
Apr-02-24 07:00PM MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting (2024 ASCO) (GlobeNewswire)
Mar-26-24 07:00PM MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan (GlobeNewswire)
Mar-20-24 07:00PM MediciNova Announces Two Abstracts regarding MN-001 (tipelukast) and MN-002 Accepted for Presentation at the 92nd EAS 2024 Congress, the Annual Meeting of the European Atherosclerosis Society (GlobeNewswire)
Mar-12-24 06:30AM MediciNova Announces New Data and Results of MN-166 (ibudilast) in Chlorine Gas-induced Acute Lung Injury Presented at the 63rd Annual Meeting of the Society of Toxicology (GlobeNewswire)
Jan-17-24 06:00AM MediciNova Receives a Notice of Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in China (GlobeNewswire)
Dec-21-23 06:00PM MediciNova Announces Abstract Regarding MN-166 (ibudilast) in Chlorine Gas-induced Lung Injury Accepted for Presentation at the 63rd Annual Meeting of the Society of Toxicology (GlobeNewswire)
Dec-06-23 06:00PM MediciNova Receives a Notice of Decision to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Progressive MS in Europe (GlobeNewswire)
Nov-19-23 06:00PM MediciNova Announces New Data and Results of a Phase 2 Clinical Trial of MN-166 (ibudilast) in Glioblastoma Presented at the 28th Annual Meeting of the Society for Neuro-Oncology (GlobeNewswire)
MediciNova, Inc. is a biopharmaceutical company, which engages in the acquisition and development of small molecule therapeutics for the treatment of diseases with unmet medical needs. The company was founded by Yuichi Iwaki on September 26, 2000, and is headquartered in La Jolla, CA.
FUBO - fuboTV Inc - Stock Price Chart
TickerFUBO [NYSE, RUT]
CompanyfuboTV Inc
CountryUSA
IndustryBroadcasting
Market Cap398.84MEPS (ttm)-0.90
P/E-EPS this Y32.09%
Forward P/E-EPS next Y48.67%
PEG-EPS past 5Y14.86%
P/S0.28EPS next 5Y-
P/B1.60EPS Q/Q49.63%
Dividend-Sales Q/Q24.04%
Insider Own3.60%Inst Own40.63%
Insider Trans-1.49%Inst Trans-5.42%
Short Float21.94%EarningsMay 03/b
Analyst Recom2.33Target Price2.95
Avg Volume10.32M52W Range1.20 - 3.87
fuboTV, Inc. engages in providing subscription to sports, news, and entertainment content. It offers its services through streaming devices and on television, mobile phones, tablets, and computers. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Haddon JulieDirectorMar 23 '24Option Exercise0.0013,058026,115Mar 26 06:52 PM
Janedis JohnChief Financial OfficerMar 04 '24Sale1.9018,00034,2120Mar 06 06:54 PM
Janedis JohnChief Financial OfficerFeb 23 '24Sale1.8530,41356,26418,000Feb 23 08:37 PM
Janedis JohnChief Financial OfficerFeb 22 '24Sale1.8922,34242,20948,413Feb 23 08:37 PM
Janedis JohnChief Financial OfficerFeb 21 '24Option Exercise0.0052,755070,755Feb 23 08:37 PM
DRD - DRDGold Ltd. ADR - Stock Price Chart
TickerDRD [NYSE]
CompanyDRDGold Ltd. ADR
CountrySouth Africa
IndustryGold
Market Cap746.06MEPS (ttm)0.84
P/E10.37EPS this Y5.06%
Forward P/E12.82EPS next Y-7.00%
PEG1.04EPS past 5Y133.83%
P/S2.37EPS next 5Y10.00%
P/B2.17EPS Q/Q-
Dividend5.19%Sales Q/Q-
Insider Own-Inst Own15.38%
Insider Trans-Inst Trans0.90%
Short Float1.54%Earnings-
Analyst Recom2.00Target Price10.36
Avg Volume349.01K52W Range6.48 - 13.73
DRDGOLD Ltd. engages in the business of retreatment of surface gold. The company was founded on February 16, 1895, and is headquartered in Johannesburg, South Africa.
NTLA - Intellia Therapeutics Inc - Stock Price Chart
TickerNTLA [NASD, RUT]
CompanyIntellia Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap2.40BEPS (ttm)-5.42
P/E-EPS this Y3.23%
Forward P/E-EPS next Y-5.42%
PEG-EPS past 5Y-22.30%
P/S66.10EPS next 5Y30.00%
P/B2.20EPS Q/Q-4.64%
Dividend-Sales Q/Q-114.12%
Insider Own2.33%Inst Own84.94%
Insider Trans-2.32%Inst Trans-0.30%
Short Float15.49%EarningsMay 09/b
Analyst Recom1.54Target Price69.57
Avg Volume1.49M52W Range19.37 - 47.48
Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BASTA JAMESEVP, General CounselMar 04 '24Sale32.992,29775,77881,571Mar 05 04:10 PM
Clark ElianaEVP, Chief Technical OfficerMar 04 '24Sale32.9960519,95971,470Mar 05 04:10 PM
Sepp-Lorenzino LauraEVP, Chief Scientific OfficerJan 08 '24Sale28.872,27565,68243,927Jan 10 04:15 PM
LEONARD JOHN MPresident and CEOJan 03 '24Sale29.4619,223566,310846,486Jan 05 04:51 PM
Lebwohl DavidEVP, Chief Medical OfficerJan 03 '24Sale29.465,843172,13554,372Jan 05 04:50 PM
LPCN - Lipocine Inc - Stock Price Chart
TickerLPCN [NASD]
CompanyLipocine Inc
CountryUSA
IndustryBiotechnology
Market Cap28.03MEPS (ttm)-3.15
P/E-EPS this Y52.70%
Forward P/E-EPS next Y-
PEG-EPS past 5Y19.47%
P/S254.85EPS next 5Y-
P/B1.37EPS Q/Q-0.82%
Dividend-Sales Q/Q-
Insider Own3.03%Inst Own8.91%
Insider Trans0.00%Inst Trans-63.19%
Short Float5.36%EarningsMay 09/b
Analyst Recom1.00Target Price33.00
Avg Volume66.54K52W Range2.31 - 7.15
Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy. The company was founded on October 13, 2011 and is headquartered in Salt Lake City, UT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Patel Mahesh V.CEO and PresidentMay 25 '23Buy5.038,70643,791107,418May 25 03:10 PM
110121314151617181920